Name : Human LILRA2/CD85h/ILT1 Protein
Product Source :
Recombinant Human LILRA2/CD85h/ILT1 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus. It contains Gly24-Asn449.[Accession | Q8N149-1]
Molecular Weight :
The protein has a predicted MW of 49.9 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Tris-Bis PAGE result.
Endotoxin Level :
Less than 1EU per μg by the LAL method.
Purity :
> 95% as determined by Tris-Bis PAGE
Formulation :
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution :
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage and Stability :
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3-6 months after reconstitution. 2-8°C for 2-7 days after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Product Concentration :
Tris-Bis PAGE Human LILRA2 on Tris-Bis PAGE under reduced conditions. The purity is greater than 95%.
Background :
LILRA2, also known as ILT1, CD85h, and LIR7, is an approximately 70 kDa variably glycosylated transmembrane protein that regulates immune cell activation. Mature human LILRA2 consists of a 426 amino acid (aa) extracellular domain (ECD) with 4 Ig-like domains, a 21 aa transmembrane segment, and a 13 aa cytoplasmic tail. LILRA2 is part of the innate immune responses against microbial infection.
Synonyms :
CD85h; ILT1; ILT-1; ILT1CD85H; LILRA2; LIR7
References & Citations :
(1)Lu H K , Ainslie M , Yasumi E , et al. LILRA2 Selectively Modulates LPS-Mediated Cytokine Production and Inhibits Phagocytosis by Monocytes[J]. PLoS ONE, 2012, 7(3):e33478-.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
STAT6 Protein
CDCP1 Protein
Popular categories:
Insulin-like Growth Factor I (IGF-1)
CD191/CCR1